PhRMA Proposes New Compendia To Guide Off-Label Rx Coverage

CMS should expand its list of drug compendia that can support coverage of off-label drug use, the Pharmaceutical Research & Manufacturers of America said in comments on a proposal to cover four cancer drugs used in clinical trials